202
Views
1
CrossRef citations to date
0
Altmetric
Retina

Attenuation of Retinal Endothelial Vasodilator Function in a Rat Model of Retinopathy of Prematurity

, , , , , , & show all
Pages 1360-1368 | Received 24 Jan 2019, Accepted 03 Jul 2019, Published online: 18 Jul 2019

References

  • Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382:1445–57. doi:10.1016/S0140-6736(13)60178-6.
  • Smith LE, Hard AL, Hellström A. The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment. Clin Perinatol. 2013;40:201–14. doi:10.1016/j.clp.2013.02.002.
  • Stone J, Itin A, Alon T, Pe’er J, Gnessin H, Chan-Ling T, Keshet E. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738–47. doi:10.1523/JNEUROSCI.15-07-04738.1995.
  • Dorrell MI, Aguilar E, Friedlander M. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Invest Ophthalmol Vis Sci. 2002;43:3500–10.
  • Saint-Geniez M, D’Amore PA. Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol. 2004;48:1045–58. doi:10.1387/ijdb.041895ms.
  • Barnett JM, Yanni SE, Penn JS. The development of the rat model of retinopathy of prematurity. Doc Ophthalmol. 2010;120:3–12. doi:10.1007/s10633-009-9180-y.
  • Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, Seaward MR, Willett KL, Aderman CM, Guerin KI, et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010;51:2813–26. doi:10.1167/iovs.10-5176.
  • Nakano A, Nakahara T, Mori A, Ushikubo H, Sakamoto K, Ishii K. Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats. Exp Eye Res. 2016;143:120–31. doi:10.1016/j.exer.2015.10.016.
  • Ueda K, Nakahara T, Hoshino M, Mori A, Sakamoto K, Ishii K. Retinal blood vessels are damaged in a rat model of NMDA-induced retinal degeneration. Neurosci Lett. 2010;485:55–59. doi:10.1016/j.neulet.2010.08.061.
  • Nakano A, Asano D, Kondo R, Mori A, Arima S, Ushikubo H, Sakamoto K, Nagamitsu T, Ishii K, Nakahara T. Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity. Exp Eye Res. 2018;168:115–27. doi:10.1016/j.exer.2017.12.007.
  • Ogawa N, Saito M, Mori A, Sakamoto K, Kametaka S, Nakahara T, Ishii K. Vasodilator effect of nicorandil on retinal blood vessels in rats. Naunyn-Schmiedeberg’s Arch Pharmacol. 2007;375:323–28. doi:10.1007/s00210-007-0165-7.
  • Mori A, Saito M, Sakamoto K, Narita M, Nakahara T, Ishii K. Stimulation of prostanoid IP and EP2 receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats. Eur J Pharmacol. 2007;570:135–41. doi:10.1016/j.ejphar.2007.05.052.
  • Nakazawa T, Kaneko Y, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K. Attenuation of nitric oxide- and prostaglandin-independent vasodilation of retinal arterioles induced by acetylcholine in streptozotocin-treated rats. Vascul Pharmacol. 2007;46:153–59. doi:10.1016/j.vph.2006.09.002.
  • Davitt BV, Wallace DK. Plus disease. Surv Ophthalmol. 2009;54:663–70. doi:10.1016/j.survophthal.2009.02.021.
  • Simonavicius N, Ashenden M, van Weverwijk A, Lax S, Huso DL, Buckley CD, Huijbers IJ, Yarwood H, Isacke CM. Pericytes promote selective vessel regression to regulate vascular patterning. Blood. 2012;120:1516–27. doi:10.1182/blood-2011-01-332338.
  • Ogura S, Kurata K, Hattori Y, Takase H, Ishiguro-Oonuma T, Hwang Y, Ahn S, Park I, Ikeda W, Kusuhara S, et al. Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown. JCI Insight. 2017;2:e90905. doi:10.1172/jci.insight.88864.
  • Park DY, Lee J, Kim J, Kim K, Hong S, Han S, Kubota Y, HG A, Ding L, Kim JW, et al. Plastic roles of pericytes in the blood-retinal barrier. Nat Commun. 2017;8:15296. doi:10.1038/ncomms15296.
  • Eilken HM, Diéguez-Hurtado R, Schmidt I, Nakayama M, Jeong HW, Arf H, Adams S, Ferrara N, Adams RH. Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1. Nat Commun. 2017;8:1574. doi:10.1038/s41467-017-01738-3.
  • Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A. Pathophysiology of diabetic retinopathy: the old and the new. Diabetes Metab J. 2018;42:364–76. doi:10.4093/dmj.2018.0182.
  • Downie LE, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Fletcher EL. AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy. Glia. 2008;56:1076–90. doi:10.1002/glia.20661.
  • Papetti M, Shujath J, Riley KN, Herman IM. FGF-2 antagonizes the TGF-beta1-mediated induction of pericyte alpha-smooth muscle actin expression: a role for myf-5 and Smad-mediated signaling pathways. Invest Ophthalmol Vis Sci. 2003;44:4994–5005. doi:10.1167/iovs.03-0291.
  • Sieczkiewicz GJ, Herman IM. TGF-beta 1 signaling controls retinal pericyte contractile protein expression. Microvasc Res. 2003;66:190–96. doi:10.1016/S0026-2862(03)00055-4.
  • Mori A, Suzuki S, Sakamoto K, Nakahara T, Ishii K. Role of calcium-activated potassium channels in acetylcholine-induced vasodilation of rat retinal arterioles in vivo. Naunyn-Schmiedeberg’s Arch Pharmacol. 2011;383:27–34. doi:10.1007/s00210-010-0570-1.
  • Mori A, Namekawa R, Hasebe M, Saito M, Sakamoto K, Nakahara T, Ishii K. Involvement of prostaglandin I2 in nitric oxide-induced vasodilation of retinal arterioles in rats. Eur J Pharmacol. 2015;764:249–55. doi:10.1016/j.ejphar.2015.07.009.
  • Ozaki H, Seo MS, Ozaki K, Yamada H, Yamada E, Okamoto N, Hofmann F, Wood JM, Campochiaro PA. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol. 2000;156:697–707. doi:10.1016/S0002-9440(10)64698-6.
  • Liu K, Akula JD, Falk C, Hansen RM, Fulton AB. The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2006;47:2639–47. doi:10.1167/iovs.06-0016.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.